1. Home
  2. ALT vs PKST Comparison

ALT vs PKST Comparison

Compare ALT & PKST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • PKST
  • Stock Information
  • Founded
  • ALT 1997
  • PKST 2008
  • Country
  • ALT United States
  • PKST United States
  • Employees
  • ALT 59
  • PKST N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • PKST Real Estate Investment Trusts
  • Sector
  • ALT Health Care
  • PKST Real Estate
  • Exchange
  • ALT Nasdaq
  • PKST Nasdaq
  • Market Cap
  • ALT 501.9M
  • PKST 514.0M
  • IPO Year
  • ALT N/A
  • PKST N/A
  • Fundamental
  • Price
  • ALT $4.86
  • PKST $13.28
  • Analyst Decision
  • ALT Strong Buy
  • PKST Strong Buy
  • Analyst Count
  • ALT 7
  • PKST 2
  • Target Price
  • ALT $16.33
  • PKST $17.50
  • AVG Volume (30 Days)
  • ALT 3.2M
  • PKST 189.0K
  • Earning Date
  • ALT 11-06-2025
  • PKST 11-05-2025
  • Dividend Yield
  • ALT N/A
  • PKST 3.04%
  • EPS Growth
  • ALT N/A
  • PKST N/A
  • EPS
  • ALT N/A
  • PKST N/A
  • Revenue
  • ALT $20,000.00
  • PKST $221,496,000.00
  • Revenue This Year
  • ALT N/A
  • PKST N/A
  • Revenue Next Year
  • ALT N/A
  • PKST N/A
  • P/E Ratio
  • ALT N/A
  • PKST N/A
  • Revenue Growth
  • ALT N/A
  • PKST 48.03
  • 52 Week Low
  • ALT $2.90
  • PKST $10.14
  • 52 Week High
  • ALT $10.88
  • PKST $15.40
  • Technical
  • Relative Strength Index (RSI)
  • ALT 68.61
  • PKST 45.19
  • Support Level
  • ALT $4.40
  • PKST $13.54
  • Resistance Level
  • ALT $4.75
  • PKST $14.19
  • Average True Range (ATR)
  • ALT 0.29
  • PKST 0.70
  • MACD
  • ALT 0.07
  • PKST -0.13
  • Stochastic Oscillator
  • ALT 95.22
  • PKST 23.74

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

Share on Social Networks: